Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong · Delayed Price · Currency is HKD 192.00
0.00 (0.00%)
Sep 2, 2026, 9:37 AM HKT
HKG:2637 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:2637 stock has a consensus rating of "Strong Buy" and an average price target of $292.89. The average 1-year stock price forecast is 52.55% higher than the current stock price, while the lowest is $282.41 (+47.09%) and the highest is $303.38 (+58.01%).
Price Target: $292.89 (+52.55%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:2637 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guohai Securities No rating | Guohai Securities | Buy Maintains $339.55 | Buy | Maintains | $339.55 | +76.85% | Sep 1, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $298.99 | Buy | Maintains | $298.99 | +55.72% | Jul 3, 2026 |
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $264.30 | Buy | Maintains | $264.30 | +37.66% | Jun 14, 2026 |
| CMB International Securities | CMB International Securities | Buy Initiates $280.00 | Buy | Initiates | $280.00 | +45.83% | Jun 10, 2026 |
Unknown Analyst Northeast Securities No rating | Northeast Securities | Buy Maintains $346.75 | Buy | Maintains | $346.75 | +80.60% | May 8, 2026 |
Financial Forecast
Revenue This Year
722.00M
from 582.36M
Increased by 23.98%
Revenue Next Year
850.00M
from 722.00M
Increased by 17.73%
EPS This Year
2.53
EPS Next Year
2.94
from 2.53
Increased by 16.21%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.